| BA | Basilar Artery |
| BAO | Basilar Artery Occlusion |
| CI | Confidence Interval |
| ECASS | European Cooperative Acute Stroke Study |
| eTICI | expanded Treatment in Cerebral Ischemia |
| EVT | Endovascular Thrombectomy |
| FI | Fragility Index |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| IA | Intra-Arterial |
| IAT | Intra-Arterial Thrombolysis |
| ICA | Internal Carotid Artery |
| ICH | Intracranial Hemorrhage |
| IVT | Intravenous Thrombolysis |
| LVO | Large-Vessel Occlusion |
| M1/M2 | First and Second Segments of the Middle Cerebral Artery |
| mRS | Modified Rankin Scale |
| OR | Odds Ratio |
| PAI-1 | Plasminogen Activator Inhibitor-1 |
| P1 | First Segment of the Posterior Cerebral Artery |
| PCA | Posterior Cerebral Artery |
| PI | Prediction Interval |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROBE | Prospective Randomized Open-Label Blinded-Endpoint |
| PROSPERO | International Prospective Register of Systematic Reviews |
| RCT | Randomized Controlled Trial |
| REML | Restricted Maximum Likelihood |
| RoB 2 | Revised Cochrane Risk of Bias Tool for Randomized Trials |
| RR | Risk Ratio |
| sICH | Symptomatic Intracranial Hemorrhage |
| TNK | Tenecteplase |
| tPA | Tissue-Type Plasminogen Activator |
| TSA | Trial Sequential Analysis |
| VA | Vertebral Artery |